↓ Skip to main content

Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition.

Overview of attention for article published in Current Pharmaceutical Design, January 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter
1 X user

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition.
Published in
Current Pharmaceutical Design, January 2018
DOI 10.2174/1381612825666190112164211
Pubmed ID
Authors

Jelena Dinić, Ana Podolski-Renić, Marko Jeremić, Milica Pešić

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 17%
Unspecified 2 9%
Student > Ph. D. Student 2 9%
Student > Bachelor 2 9%
Librarian 1 4%
Other 4 17%
Unknown 8 35%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 13%
Pharmacology, Toxicology and Pharmaceutical Science 2 9%
Immunology and Microbiology 2 9%
Medicine and Dentistry 2 9%
Chemistry 2 9%
Other 4 17%
Unknown 8 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 September 2022.
All research outputs
#17,292,294
of 25,385,509 outputs
Outputs from Current Pharmaceutical Design
#2,503
of 3,702 outputs
Outputs of similar age
#283,834
of 449,583 outputs
Outputs of similar age from Current Pharmaceutical Design
#103
of 235 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,702 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 449,583 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 235 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.